ClinACE Appoints Dr. Richard Rosenbloom On Its Medical Advisory Panel
ClinACE, a privately held Contract Research Organization (CRO) announced the appointment of US based Dr. Richard Rosenbloom on its Medical Advisory Panel.
- (1888PressRelease) December 22, 2010 - Mumbai, India - ClinACE, a privately held Contract Research Organization (CRO) with operations mainly in India and business partners worldwide, announced the appointment of US based Dr. Richard Rosenbloom on its Medical Advisory Panel.
"This new addition ensures the company will continue to benefit from a diversity of knowledge and opinions" said Jayesh Chaudhary, Chief Executive Officer, ClinACE
Dr. Rosenbloom, Doctor of Medicine (M.D.) and Doctor of Philosophy (Ph.D.) in Nutrition Science has served in Senior management positions of Medical Director, Medical Affairs Director, Chief Operating Officer and Chief Medical Officer in accredited Research and Development American Firms in a brilliant career spanning over a decade. "I resonate Jayesh's thoughts and also feel that ClinACE would be able to penetrate into new geographies with his expertise and experience" adds Kunal Bhatt, Global Business Development Manager. An accomplished and groundbreaking medical researcher, executive, and leader with extensive experience developing pioneering therapies for the treatment of cancer, diabetes, and central nervous system disorders. Equipped with a strong portfolio of accomplishments encompassing the origination of highly successful proprietary drugs, holding more than 40 active international patents. "We look forward to the dynamism and expertise of Dr. Rosenbloom to guide us ably in the creation of affordable, credible and efficient drug development solutions", as quoted by Shefali Roy, Manager Marketing.
About ClinACE
ClinACE is a privately held Contract Research Organization (CRO) with operations mainly in India and business partners worldwide. We provide full service support for Phase II-IV, Post Marketing Surveillance (PMS), clinical equivalence and other clinical trials to support Medical Devices, NDA and 505(b)(2) submissions for the Pharmaceutical Innovative Drugs and Generics industries in India and abroad. Our expertise is in therapeutic areas like Orthopedics, Urology, Andrology, Diabetology, Metabolic Diseases, Respiratory, Infectious Diseases, HIV, Dermatology and Gastroenterology.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam